Видео ютуба по тегу Biologicdevelopment

Mass Spec Approaches to Supporting Biologic Development
Mass Spec Approaches to Supporting Biologic Development
De-risking Biologic Development: Engineering Flexibility from Early Development to Launch
De-risking Biologic Development: Engineering Flexibility from Early Development to Launch
Landscape of OA Drug and Biologic Development, CDER Regulatory Perspective | Robert Shibuya
Landscape of OA Drug and Biologic Development, CDER Regulatory Perspective | Robert Shibuya
Watch Webinar: Advanced Tools to Shorten Biologic Development Timelines
Watch Webinar: Advanced Tools to Shorten Biologic Development Timelines
Navigating FDA: Drug (and Biologic) Development Requirements
Navigating FDA: Drug (and Biologic) Development Requirements
Landscape of OA Drug and Biologic Development, CBER Regulatory Perspective | Elizabeth Hart
Landscape of OA Drug and Biologic Development, CBER Regulatory Perspective | Elizabeth Hart
Types of Drug & Biologic Submissions
Types of Drug & Biologic Submissions
Small Molecule vs Biologics
Small Molecule vs Biologics
💊 Journey of a Biologic Drug – From Lab to Market
💊 Journey of a Biologic Drug – From Lab to Market
CHO Cell Line Development — From DNA to IND Ready with Certainty
CHO Cell Line Development — From DNA to IND Ready with Certainty
BioPharma Summits - ADC Characterization on a Single Platform with Q Exactive BioPharma
BioPharma Summits - ADC Characterization on a Single Platform with Q Exactive BioPharma
Meet the Expert: James Valentine and Richard Lewis
Meet the Expert: James Valentine and Richard Lewis
Catalent: An Innovative Approach
Catalent: An Innovative Approach
Plant-Based Biologics With iBio's Randy Maddux
Plant-Based Biologics With iBio's Randy Maddux
Reshoring Biologics Development and Manufacturing for a Streamlined Path to IND
Reshoring Biologics Development and Manufacturing for a Streamlined Path to IND
The FDA's New Playbook: Biosimilars, National Priority Vouchers, and the Plausible Mechanism Pathway
The FDA's New Playbook: Biosimilars, National Priority Vouchers, and the Plausible Mechanism Pathway
What does the Clin Pharm Plan for a Biologic Look Like?
What does the Clin Pharm Plan for a Biologic Look Like?
Importance of Regulatory Affairs in the Process of Drug Development: Clinreg Partners
Importance of Regulatory Affairs in the Process of Drug Development: Clinreg Partners
Adolescent Growth and Development Milestones Nursing NCLEX Teen Review
Adolescent Growth and Development Milestones Nursing NCLEX Teen Review
Intact Mass and Subunit Analysis | BioAccord System Demo | 3 of 5
Intact Mass and Subunit Analysis | BioAccord System Demo | 3 of 5
Introduction to Systematic Review & Meta Analysis - Sir Junaid
Introduction to Systematic Review & Meta Analysis - Sir Junaid
Catalent: Why Catalent
Catalent: Why Catalent